Who Owns Legend Biotech Stock?
NASDAQ: LEGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 55.10%
- Held by insiders
- 1.90%
- Institutional holders
- 321
- Institutions 55.1%
- Insiders 1.9%
- Public and other 43.0%
Who owns Legend Biotech stock?
Institutional investors own about 55.1% of Legend Biotech's shares, spread across 321 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.90% of LEGN.
The largest institutional holders are FMR, LLC (12.47%), Kynam Capital Management, LP (4.72%) and HHLR Advisors, LTD (4.31%). Together, the top 10 institutions control 36.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their LEGN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LEGN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 24.20M | 12.47% | -16.8% |
| Kynam Capital Management, LP | 9.15M | 4.72% | +205.0% |
| HHLR Advisors, LTD | 8.36M | 4.31% | +39.7% |
| Deerfield Management Company, L.P | 8.14M | 4.20% | 0.0% |
| Montanova Capital LLC | 6.23M | 3.21% | -11.9% |
| Westfield Capital Management Co LP | 5.15M | 2.66% | +16.3% |
| Blackrock Inc. | 5.09M | 2.63% | +7.8% |
| State Street Corporation | 1.62M | 0.83% | +8.1% |
| Point72 Asset Management, L.P. | 1.60M | 0.83% | -47.8% |
| Elmind Capital, LP | 1.57M | 0.81% | +175.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LEGN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Select Portfolios-Select Pharmaceuticals Portfolio | 2.59M | 1.34% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 2.53M | 1.30% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 2.28M | 1.18% |
| Fidelity Contrafund | 1.92M | 0.99% |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 1.89M | 0.97% |
| Fidelity Investment Trust-Fidelity Emerging Markets Fund | 1.73M | 0.89% |
| HARBOR FUNDS-Harbor Small Cap Growth Fund | 1.35M | 0.70% |
| iShares Trust-iShares Biotechnology ETF | 1.28M | 0.66% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 1.08M | 0.56% |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 956.36K | 0.49% |
Frequently asked questions
Who is the largest shareholder of Legend Biotech?
FMR, LLC is the largest institutional shareholder of LEGN, owning 12.47% of shares outstanding (24.20M shares) as of its latest 13F filing.
What percentage of Legend Biotech is owned by institutions?
Institutions own about 55.1% of LEGN shares and 56.2% of the public float.
How much of Legend Biotech do insiders own?
Insiders, such as officers and directors, own about 1.90% of LEGN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.